John Shyi Peng YUEN

Dr. John Shyi Peng YUEN


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JTJoshua Yi Min Tung
Joshua Yi Min Tung
QLQuan Le
Quan Le
JYJinxuan Yao
Jinxuan Yao
YHYifei Huang
Yifei Huang
DLDaniel Yan Zheng Lim
Daniel Yan Zheng Lim
HHHenry Sun Sien Ho
Henry Sun Sien Ho
Background: Prostate-specific antigen (PSA) testing remains the cornerstone of early prostate cancer detection. Society guidelines for prostate cancer screening via PSA testing serve to standardize patient care and are often used by trainees, junior staff, or generalist medical practitioners to guide medical decision-making. However, adherence to guidelines is a time-consuming and challenging task, and rates of inappropriate PSA testing are high. Retrieval-augmented generation (RAG) is a method to enhance the reliability of large language models (LLMs) by grounding responses in trusted external sources. Objective: This study aimed to evaluate a RAG-enhanced LLM system, grounded in current European Association of Urology and American Urological Association guidelines, to assess its effectiveness in providing guideline-concordant PSA screening recommendations compared to junior clinicians. Methods: A series of 44 fictional outpatient case scenarios was developed to represent a broad spectrum of clinical presentations. A RAG pipeline was developed, comprising a life expectancy estimation module based on the Charlson Comorbidity Index, followed by LLM-generated recommendations constrained to retrieved excerpts from the European Association of Urology and American Urological Association guidelines. Five junior clinicians were tasked to provide PSA testing recommendations for the same scenarios in closed-book and open-book formats. Answers were compared for accuracy in a binomial fashion. Fleiss κ was computed to assess interrater agreement among clinicians. Results: The RAG-LLM tool provided guideline-concordant recommendations in 95.5% (210/220) of case scenarios, compared to junior clinicians, who were correct in 62.3% (220) of scenarios in a closed-book format and 74.1% (220) of scenarios in an open-book format. The difference was statistically significant for both closed-book ( P <.001) and open-book ( P <.001) formats. Interrater agreement among clinicians was fair, with Fleiss κ of 0.294 and 0.321 for closed-book and open-book formats, respectively. Conclusions: Use of RAG techniques allows LLMs to integrate complex guidelines into day-to-day medical decision-making. RAG-LLM tools in urology have the capability to enhance clinical decision-making by providing guideline-concordant recommendations for PSA testing, potentially improving the consistency of health care delivery, reducing cognitive load on clinicians, and reducing unnecessary investigations and costs. While this study used synthetic cases in a controlled simulation environment, it establishes a foundation for future validation in real-world clinical settings.

1 July 2018 in Asian Journal of Urology
Verified
Journal Article
Open access
KCKenneth Chen
Kenneth Chen
KTKae Jack Tay
Kae Jack Tay
YLYan Mee Law
Yan Mee Law
HAHakan Aydin
Hakan Aydin
HHHenry Ho
Henry Ho
JYJohn Shyi Peng YUEN
John Shyi Peng YUEN
Active surveillance (AS) offers a strategy to reduce overtreatment and now is a widely accepted treatment option for low-risk prostate cancer. An ideal tool for risk-stratification would detect aggressive cancers and exclude such men from taking up AS in the first place. We evaluate if a combination of transperineal template biopsy with magnetic resonance imaging (MRI)-targeted biopsy identifies significant prostate cancer amongst men initially diagnosed with low-risk prostate cancer. This prospective, single-blinded study included men with low-risk prostate cancer (D'Amico's Criteria) diagnosed on conventional transrectal ultrasound-guided biopsy. Patients first underwent multiparametric MRI of the prostate ≥6 weeks after initial biopsy. Each suspicious lesion is mapped and assigned a Prostate Imaging Reporting and Data System (PIRADS) score. Template biopsy is first performed with the surgeon blinded to MRI findings followed by MRI-targeted biopsy using a robotic transperineal biopsy platform. The age of the 19 men included is 65.4 ± 4.9 years (mean ± SD). Prostate specific antigen (PSA) at diagnosis and at the time of transperineal biopsy were comparable (7.3 ± 1.7 ng/mL and 7.0 ± 1.8 ng/mL, p = 0.67), so were prostate volumes (34.2 ± 8.9 mL and 32.1 ± 13.4 mL, p = 0.28). MRI-targeted biopsy had a higher percentage of cancer detection per core compared to template biopsy (11.7% vs. 6.5%, p = 0.02), this was more than 3 times superior for Gleason 7 disease (5.9% vs. 1.6%, p < 0.01). Four of 18 (22.2%) patients with MRI lesions had significant disease with MRI-targeted biopsy alone. Three of 19 patients (15.8%) had significant disease with template biopsy alone. In combination, both techniques upclassified five patients (26.3%), all of whom underwent radical prostatectomy. Whole mount histology confirmed tumour location and grade. All six patients with PIRADS 5 lesions had cancer detected (66.6% significant disease). A combination of MRI-targeted and template biopsy may optimally risk-classify "low-risk" patients diagnosed on initial conventional transrectal ultrasonography (TRUS) prostate biopsy.

11 January 2021 in The Prostate
Verified
Journal Article
Closed access
PDF file
YTYu Guang Tan
Yu Guang Tan
FKFarhan Khalid
Farhan Khalid
HHHong Hong Huang
Hong Hong Huang
KCKenneth Chen
Kenneth Chen
KTKae Jack Tay
Kae Jack Tay
JYJohn Shyi Peng YUEN
John Shyi Peng YUEN

1 May 2021 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
ALAlvin Wx Low
Alvin Wx Low
KCKenneth Chen
Kenneth Chen
YTYu Guang Tan
Yu Guang Tan
TNTze Kiat Ng
Tze Kiat Ng
JYJohn Shyi Peng YUEN
John Shyi Peng YUEN

17 September 2025 in Cancers
Verified
Journal Article
Open access
PDF file
YTYu Guang Tan
Yu Guang Tan
KFKhi Yung Fong
Khi Yung Fong
NGNathanael Goh
Nathanael Goh
ALAlvin Ym Lee
Alvin Ym Lee
KTKae Jack Tay
Kae Jack Tay
KCKenneth Chen
Kenneth Chen
Background: Long-term survival in penile cancer is dependent on the presence and extent of lymph node metastases. Historically, inguinal lymph node dissection (ILND) has been performed via an open approach (O-ILND). More recently, minimally invasive surgical alternatives (MIS-ILND) such as video-endoscopic and robot-assisted ILND have emerged. This review aims to compare the (1) perioperative outcomes, (2) complication rates, and (3) oncological efficacy between O-ILND and MIS-ILND. Methods: We conducted a PRISMA-compliant meta-analysis including studies comparing O-ILND versus MIS-ILND for penile cancer. Outcomes were pooled in random-effects meta-analyses. Results: Sixteen articles comprising 1054 patients were analysed. There was an observed trend towards longer operative time for the MIS-ILND approach (mean difference 28 min; 95% CI −2 to 58 min, p = 0.06), particularly with the robotic-assisted technique. Total LN yield (mean 12.3, mean difference 0.3, 95% CI −0.3 to 0.9, p = 0.13), and positive LN (RR 0.98, 95% CI 0.88–1.10, p = 0.75) were similar between groups. MIS-ILND significantly reduced complication rates for both minor (RR: 0.65, 95% CI 0.45–0.94, p = 0.02) and major complications (RR: 0.25, 95% CI 0.12–0.53, p = 0.002). Particularly, there was also lower wound infection rate with MIS-ILND (RR: 0.43, 95% CI 0.22–0.82, p = 0.02), corresponding to a shorter hospital stay of average 4 days (MD −4, 95% CI −6–−2, p = 0.05). Rates of skin/flap necrosis, lymphedema, lymphocele, and drainage time did not differ significantly. Local groin recurrence and overall survival did not differ between approaches. Conclusions: MIS-ILND is associated with fewer perioperative complications and shorter hospitalisation without compromising oncologic outcomes. These findings support its broader adoption, particularly in high-volume centres with appropriate surgical expertise.

24 October 2024 in Medicina
Verified
Journal Article
Open access
PDF file
RGRene Gatsinga
Rene Gatsinga
BLBenjamin J. H. Lim
Benjamin J. H. Lim
NKNavin Kumar
Navin Kumar
JTJacinda Tan
Jacinda Tan
YLYouquan Li
Youquan Li
JYJohn Shyi Peng YUEN
John Shyi Peng YUEN
Background and Objectives: Radiation therapy (RT) plays a crucial role in managing prostate cancer, offering effective disease control and improving survival rates in both localized and recurrent cases. However, RT can lead to hemorrhagic cystitis, a significant late complication resulting in chronic morbidity and other health issues. This study aims to evaluate the real-world incidence of radiation-induced hemorrhagic cystitis requiring surgical intervention. Materials and Methods: This retrospective cohort study analyzed data from prostate cancer survivors treated for hematuria at our center between January 2014 and January 2024. Patients were included if cystoscopy identified radiation cystitis as the cause of hematuria. Descriptive statistics were used, and binomial logistic regression analyses with univariate and multivariate analysis were performed to identify risk factors for worse outcomes. Results: Fifty-two patients met the inclusion criteria. The estimated cumulative incidence at a median follow-up of 5.3 years was 4.5%. Among the participants, 21.2% required more than two transurethral bladder fulguration (TUBF) procedures, and 38.5% needed more than two hospital admissions for hematuria management. The median time to the first fulguration was 64 months. Blood transfusions were necessary in 53.8% of cases, and 38.5% required hyperbaric oxygen therapy. Ultimately, 5.8% of the patients underwent cystectomy. Univariate analysis identified ischemic heart disease (IHD) and antiplatelet therapy as significant risk factors (OR: 5.17 and 5.18, respectively), along with longer time to first fulguration (OR: 5.02). Multivariate analysis confirmed antiplatelet therapy (OR: 2.8, p = 0.05) and time to first TUBF (OR: 1.8, p = 0.02) as significant predictors of multiple procedures. Conclusions: Radiation cystitis remains a significant burden on prostate cancer survivors. Patients on antithrombotic agents, those with delayed initial presentations, and those who received radiation as salvage therapy are more likely to experience higher morbidity.